{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:23:45Z","timestamp":1790274225069,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE-1895\/4-1"],"award-info":[{"award-number":["STE-1895\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5278-0","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T14:03:03Z","timestamp":1547560983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Lisa","family":"Traeger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Ellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Wiethoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Ihbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Gallitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eveslage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Jan","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-961X","authenticated-orcid":false,"given":"Andrea U.","family":"Steinbicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"issue":"43","key":"5278_CR1","doi-asserted-by":"publisher","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","volume":"2","author":"ZK Pinnix","year":"2010","unstructured":"Pinnix ZK, Miller LD, Wang W, Jr D\u2019AR, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010;2(43):43ra56.","journal-title":"Sci Transl Med"},{"key":"5278_CR2","unstructured":"Winand FJ, Boegemann M, Gallitz I, Hertle L, Semjonow A, Eveslage M, Van Aken HK, Herrmann E, Steinbicker AU: GDF15 and Hepcidin as prognostic factors in patients with prostate Cancer. Molecular Biomarkers & Diagnosis 2014, 5(6)."},{"issue":"11","key":"5278_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-14-2465","volume":"75","author":"L Tesfay","year":"2015","unstructured":"Tesfay L, Clausen KA, Kim JW, Hegde P, Wang X, Miller LD, Deng Z, Blanchette N, Arvedson T, Miranti CK, Babitt JL, Lin HY, Peehl DM, Torti FM, Torti SV. Hepcidin regulation in prostate and its disruption in prostate cancer. Cancer Res. 2015;75(11):2254\u201363.","journal-title":"Cancer Res"},{"issue":"5704","key":"5278_CR4","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090\u20133.","journal-title":"Science"},{"issue":"9","key":"5278_CR5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434\u201343.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"5278_CR6","doi-asserted-by":"publisher","first-page":"e1004998","DOI":"10.1371\/journal.ppat.1004998","volume":"11","author":"K Michels","year":"2015","unstructured":"Michels K, Nemeth E, Ganz T, Mehrad B. Hepcidin and host defense against infectious diseases. PLoS Pathog. 2015;11(8):e1004998.","journal-title":"PLoS Pathog"},{"issue":"2","key":"5278_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.gene.2012.09.060","volume":"511","author":"Y Hou","year":"2012","unstructured":"Hou Y, Zhang S, Wang L, Li J, Qu G, He J, Rong H, Ji H, Liu S. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene. 2012;511(2):398\u2013403.","journal-title":"Gene"},{"issue":"2","key":"5278_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/hep.26648","volume":"59","author":"C Latour","year":"2014","unstructured":"Latour C, Kautz L, Besson-Fournier C, Island ML, Canonne-Hergaux F, Loreal O, Ganz T, Coppin H, Roth MP. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology. 2014;59(2):683\u201394.","journal-title":"Hepatology"},{"key":"5278_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1471-2407-9-270","volume":"9","author":"T Kamai","year":"2009","unstructured":"Kamai T, Tomosugi N, Abe H, Arai K, Yoshida K. Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer. 2009;9:270\u20132407 9-270.","journal-title":"BMC Cancer"},{"issue":"4","key":"5278_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00277-014-2255-1","volume":"94","author":"M Hara","year":"2015","unstructured":"Hara M, Ando M, Tsuchiya K, Nitta K. Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma. Ann Hematol. 2015;94(4):603\u20138.","journal-title":"Ann Hematol"},{"issue":"1","key":"5278_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1759-7714.12046","volume":"5","author":"Q Chen","year":"2014","unstructured":"Chen Q, Wang L, Ma Y, Wu X, Jin L, Yu F. Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage. Thorac Cancer. 2014;5(1):14\u201324.","journal-title":"Thorac Cancer"},{"issue":"2","key":"5278_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/annonc\/mdt490","volume":"25","author":"R Orlandi","year":"2014","unstructured":"Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, Bongarzone I. Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer. Ann Oncol. 2014;25(2):352\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"5278_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/nyas.13008","volume":"1368","author":"DH Manz","year":"2016","unstructured":"Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV. Iron and cancer: recent insights. Ann N Y Acad Sci. 2016;1368(1):149\u201361.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"5278_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/pcan.2012.6","volume":"15","author":"P Vanhara","year":"2012","unstructured":"Vanhara P, Hampl A, Kozubik A, Soucek K. Growth\/differentiation factor-15: prostate cancer suppressor or promoter? Prostate Cancer Prostatic Dis. 2012;15(4):320\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"5278_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","volume":"68","author":"M Roupret","year":"2015","unstructured":"Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Bohle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF. European Association of Urology guidelines on upper urinary tract Urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68(5):868\u201379.","journal-title":"Eur Urol"},{"key":"5278_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-35032-0","volume-title":"Uroonkologie","author":"H R\u00fcbben","year":"2014","unstructured":"R\u00fcbben H. Uroonkologie. 6th ed. Berlin Heidelberg: Springer; 2014.","edition":"6"},{"issue":"6","key":"5278_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG. Upper tract Urothelial carcinoma CollaborationThe upper tract Urothelial carcinoma collaboration: outcomes of radical nephroureterectomy: a series from the upper tract Urothelial carcinoma collaboration. Cancer. 2009;115(6):1224\u201333.","journal-title":"Cancer"},{"key":"5278_CR18","volume-title":"Urologie","author":"RGJ Hautmann","year":"2014","unstructured":"Hautmann RGJ. Urologie. 5th ed. Berlin Heidelberg: Springer; 2014.","edition":"5"},{"key":"5278_CR19","doi-asserted-by":"crossref","unstructured":"Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Bohle A, Palou Redorta J, Roupret M, European Association of Urology: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013, 64(4):639\u2013653.","DOI":"10.1016\/j.eururo.2013.06.003"},{"issue":"6","key":"5278_CR20","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.eururo.2014.11.001","volume":"67","author":"P Li","year":"2015","unstructured":"Li P, Znaor A, Holcatova I, Fabianova E, Mates D, Wozniak MB, Ferlay J, Scelo G. Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol. 2015;67(6):1134\u201341.","journal-title":"Eur Urol"},{"issue":"3","key":"5278_CR21","doi-asserted-by":"publisher","first-page":"e000013","DOI":"10.1136\/esmoopen-2015-000013","volume":"1","author":"A Rodriguez-Vida","year":"2016","unstructured":"Rodriguez-Vida A, Strijbos M, Hutson T. Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma. ESMO Open. 2016;1(3):e000013.","journal-title":"ESMO Open"},{"issue":"8","key":"5278_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","volume":"115","author":"KC Wollert","year":"2007","unstructured":"Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation. 2007;115(8):962\u201371.","journal-title":"Circulation"},{"key":"5278_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1515\/med-2017-0027","volume":"12","author":"P Xiang-Tao","year":"2017","unstructured":"Xiang-Tao P. Expression of Hepcidin and Neogenin in colorectal Cancer. Open Med (Wars). 2017;12:184\u20138.","journal-title":"Open Med (Wars)"},{"issue":"5","key":"5278_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/ijc.30797","volume":"141","author":"P Jakszyn","year":"2017","unstructured":"Jakszyn P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, Tous M, Arija V, Cross A, Bueno-de-Mesquita HBA, Weiderpass E, Kuhn T, Kaaks R, Sjoberg K, Ohlsson B, Tumino R, Palli D, Ricceri F, Fasanelli F, Krogh V, Mattiello A, Jenab M, Gunter M, Perez-Cornago A, Khaw KT, Tjonneland A, Olsen A, Overvad K, Trichopoulou A, Peppa E, Vasilopoulou E, Boeing H, Sanchez-Cantalejo E, Huerta JM, Dorronsoro M, Barricarte A, Quiros JM, Peeters PH, Agudo A. Hepcidin levels and gastric cancer risk in the EPIC-EurGast study. Int J Cancer. 2017;141(5):945\u201351.","journal-title":"Int J Cancer"},{"issue":"1","key":"5278_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12185-017-2366-2","volume":"107","author":"T Ganz","year":"2018","unstructured":"Ganz T. Iron and infection. Int J Hematol. 2018;107(1):7\u201315.","journal-title":"Int J Hematol"},{"issue":"9","key":"5278_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/abbs\/gmv063","volume":"47","author":"W Guo","year":"2015","unstructured":"Guo W, Zhang S, Chen Y, Zhang D, Yuan L, Cong H, Liu S. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis. Acta Biochim Biophys Sin Shanghai. 2015;47(9):703\u201315.","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"21","key":"5278_CR27","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","volume":"15","author":"DA Brown","year":"2009","unstructured":"Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL, Xu J, Isaacs WB, Gronberg H, Breit SN, Wiklund FE. Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res. 2009;15(21):6658\u201364.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5278_CR28","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1073\/pnas.0530278100","volume":"100","author":"JB Welsh","year":"2003","unstructured":"Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson HF Jr, Hampton GM. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci U S A. 2003;100(6):3410\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5278_CR29","first-page":"535","volume":"21","author":"L Lu","year":"2017","unstructured":"Lu L, Ma GQ, Liu XD, Sun RR, Wang Q, Liu M, Zhang PY. Correlation between GDF15, MMP7 and gastric cancer and its prognosis. Eur Rev Med Pharmacol Sci. 2017;21(3):535\u201341.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"5278_CR30","doi-asserted-by":"publisher","first-page":"16972","DOI":"10.18632\/oncotarget.15216","volume":"8","author":"Q Xu","year":"2017","unstructured":"Xu Q, Xu HX, Li JP, Wang S, Fu Z, Jia J, Wang L, Zhu ZF, Lu R, Yao Z. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT\/GSK-3beta\/beta-catenin signaling. Oncotarget. 2017;8(10):16972\u201387.","journal-title":"Oncotarget"},{"issue":"12","key":"5278_CR31","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.jid.2016.07.016","volume":"136","author":"B Weide","year":"2016","unstructured":"Weide B, Schafer T, Martens A, Kuzkina A, Uder L, Noor S, Garbe C, Harter PN, Mittelbronn M, Wischhusen J. High GDF-15 serum levels independently correlate with poorer overall survival of patients with tumor-free stage III and Unresectable stage IV melanoma. J Invest Dermatol. 2016;136(12):2444\u201352.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"5278_CR32","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/jcmm.12830","volume":"20","author":"C Li","year":"2016","unstructured":"Li C, Wang X, Casal I, Wang J, Li P, Zhang W, Xu E, Lai M, Zhang H. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. J Cell Mol Med. 2016;20(8):1420\u20136.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5278_CR33","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.21873\/anticanres.11477","volume":"37","author":"J Windrichova","year":"2017","unstructured":"Windrichova J, Fuchsova R, Kucera R, Topolcan O, Fiala O, Finek J, Slipkova D. MIC1\/GDF15 as a bone metastatic disease biomarker. Anticancer Res. 2017;37(3):1501\u20135.","journal-title":"Anticancer Res"},{"issue":"1","key":"5278_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000473891","volume":"83","author":"CA Lima","year":"2018","unstructured":"Lima CA, Jammal MP, Martins-Filho A, Silveira TP, Micheli DC, Tavares-Murta BM, Murta EFC, Nomelini RS. Stromal growth differentiation factor 15 and its association with ovarian Cancer. Gynecol Obstet Investig. 2018;83(1):35\u20139.","journal-title":"Gynecol Obstet Investig"},{"issue":"7","key":"5278_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00345-018-2235-5","volume":"36","author":"MD Vartolomei","year":"2018","unstructured":"Vartolomei MD, Kimura S, Ferro M, Vartolomei L, Foerster B, Abufaraj M, Shariat SF. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. World J Urol. 2018;36(7):1019\u201329.","journal-title":"World J Urol"},{"issue":"9","key":"5278_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.urolonc.2018.05.014","volume":"36","author":"MD Vartolomei","year":"2018","unstructured":"Vartolomei MD, Porav-Hodade D, Ferro M, Mathieu R, Abufaraj M, Foerster B, Kimura S, Shariat SF. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis. Urol Oncol. 2018;36(9):389\u201399.","journal-title":"Urol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5278-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T14:57:54Z","timestamp":1606057074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5278-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5278"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5278-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the Ethical Committee of the University of Muenster (Study No 2014\u2013181-f-S). All patients and controls involved in the study provided a written approval to store serum samples, measure serum hepcidin and GDF-15 level, and retrospectively analyze it in relation to patient\u2019s medical history and demographical data. The study was performed according to the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"74"}}